Yıl: 2021 Cilt: 43 Sayı: 3 Sayfa Aralığı: 282 - 287 Metin Dili: İngilizce DOI: 10.14744/etd.2020.22308 İndeks Tarihi: 15-02-2022

Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome

Öz:
Objective: During sleep, blood pressure (BP) is generally 10%–20% lower, and the risk of target organ damage in non-dip per hypertension (HT) is related to left ventricle hypertrophy, MI, and stroke. This study aimed to analyze the effect ofnon-dipper HT on the prevalence of coronary artery disease (CAD), time of symptom onset, and in-hospital MACE in pa tients with acute coronary syndrome (ACS). Materials and Methods: We included 107 patients who were diagnosed with ACS and had angina pectoris lasting 12 h atmost and no history of CAD in this study. Patients’ ambulatory BP was monitored for 24 h. Patients were divided into thenon-hipper and dipper groups according to the decrease in BP during nighttime. We compared the prevalence of CAD, timeof symptom onset, and in-hospital MACE in both groups. Results: We included 52 patients in the non-dipper group and 55 patients in the dipper group in this study. When wecompared the Syntax and Gensini scores between the groups, statistical significance was determined (p=0.006). In terms ofsymptom onset hours, 32 (62%) and 19 (35%) patients were admitted with night angina pectoris in the non-dipper and dip per groups, respectively (p=0.007). In terms of in-hospital MACE ratios, we identified MACE in six patients in the non-dippergroup and three patients in the dipper group (p=0.223). Conclusion: In our study, we conclude that non-dipper HT increases the number of lesions, MI cases at night, and MACEratios in CAD by causing endothelium dysfunction and stimulating thrombocyte activation.
Anahtar Kelime:

Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. White HD, Chew DP. Acute myocardial infarction. Lancet 2008; 372(9638): 570–84.
  • 2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 2001; 104(3): 365–72.
  • 3. Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Collantes E, Aguirre MA, Perez-Sanchez C. New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches. Front Immunol 2019; 10: 764.
  • 4. Holm NR, Mäkikallio T, Lindsay MM, Spence MS, Erglis A, Menown IBA, et al. Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial. Lancet 2020; 395(10219): 191–9.
  • 5. Mills KT, Stefanescu A, He J. The global epidemiology of hypertension. Nat Rev Nephrol 2020; 16(4): 223–37.
  • 6. Millar-Craig MW, Bishop CN, Raftery EB. Circadian variation of bloodpressure. Lancet 1978; 1(8068): 795–7.
  • 7. Seo WS, Oh HS. The circadian rhythms of blood pressure and heart rate in the hypertensive subjects: dippers and non-dippers. Yonsei Med J 2002; 43(3): 320–8.
  • 8. Hermida RC, Calvo C, Ayala DE, Domínguez MJ, Covelo M, Fernández JR, et al. Administration time-dependent effects of valsartan on ambulatory blood pressure in hypertensive subjects. Hypertension 2003; 42(3): 283–90.
  • 9. Pierdomenico SD, Costantini F, Bucci A, De Cesare D, Bucciarelli T, Cuccurullo F, et al. Blunted nocturnal fall in blood pressure and oxidative stress in men and women with essential hypertension. Am J Hypertens 1999; 12(4 Pt 1): 356–63.
  • 10. Takeda A, Toda T, Fujii T, Matsui N. Bedtime administration of longacting antihypertensive drugs restores normal nocturnal blood pressure fall in nondippers with essential hypertension. Clin Exp Nephrol 2009; 13(5): 467–72.
  • 11. Murphy JG. Mayo clinic Cardiology review. The Endothelium. 2nd edition. Lippincott Williams & Wilkins 2001.p. 99–106.
  • 12. Landmesser U, Drexler H. The clinical significance of endothelial dysfunction. Curr Opin Cardiol 2005; 20(6): 547–51.
  • 13. Fujii T, Uzu T, Nishimura M, Takeji M, Kuroda S, Nakamura S, et al. Circadian rhythm of natriuresis is disturbed in nondipper type of essential hypertension. Am J Kidney Dis 1999; 33(1): 29–35.
  • 14. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M, et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20(11): 2183–9.
  • 15. Pierdomenico SD, Bucci A, Costantini F, Lapenna D, Cuccurullo F, Mezzetti A. Circadian blood pressure changes and myocardial ischemia in hypertensive patients with coronary artery disease. J Am Coll Cardiol 1998; 31(7): 1627–34.
  • 16. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart Disease? The Framing- ham heart study. Circulation 1999; 100(4): 354–60.
  • 17. Libby P, Buring JE, Badimon L, Hansson GK, Deanfield J, Bittencourt MS, et al. Atherosclerosis. Nat Rev Dis Primers 2019; 5(1): 56.
  • 18. Higashi Y, Nakagawa K, Kimura M, Noma K, Hara K, Sasaki S, et al. Circadian variation of blood pressure and endothelial function in patients with essential hypertension:a comparison of dippers and nondippers. J Am Coll Cardiol 2002; 40(11): 2039–43.
  • 19. Kaya MG, Yarlioglues M, Gunebakmaz O, Gunturk E, Inanc T, Dogan A, et al. Platelet activation and inflammatory response in patients with non-dipper hypertension. Atherosclerosis 2010; 209(1): 278–82
  • 20. White WB. Importance of blood pressure control over a 24-hour period. J Manag Care Pharm 2007; 13(8 Suppl B): 34–9.
  • 21. Remme WJ. The sympathetic nervous system and ischaemic heart disease. Eur Heart J 1998; 19 Suppl F: F62–F71.
  • 22. Alexander RW, Schlant RC, Fuster V. Hurst’s The Heart. 9th edition. New York: McGraw-Hill; 1998.p. 110–757.
  • 23. Bahçivan M, Gülel O, Kolbakir F. The effect of preoperative circadian blood pressure pattern on early postoperative outcomes in patients with coronary artery bypass graft surgery. Anadolu Kardiyol Derg 2008; 8(5): 354–9.
APA ELÇİK D, Kelesoglu S, Dogan A, BİNGÖL B, ÇETİNKAYA Z, İİNANÇ M, KALAY N, TOPSAKAL R, Oğuzhan A (2021). Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. , 282 - 287. 10.14744/etd.2020.22308
Chicago ELÇİK Deniz,Kelesoglu Saban,Dogan Ali,BİNGÖL Bilge,ÇETİNKAYA Zeki,İİNANÇ M. Tuğrul,KALAY Nihat,TOPSAKAL Ramazan,Oğuzhan Abdurrahman Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. (2021): 282 - 287. 10.14744/etd.2020.22308
MLA ELÇİK Deniz,Kelesoglu Saban,Dogan Ali,BİNGÖL Bilge,ÇETİNKAYA Zeki,İİNANÇ M. Tuğrul,KALAY Nihat,TOPSAKAL Ramazan,Oğuzhan Abdurrahman Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. , 2021, ss.282 - 287. 10.14744/etd.2020.22308
AMA ELÇİK D,Kelesoglu S,Dogan A,BİNGÖL B,ÇETİNKAYA Z,İİNANÇ M,KALAY N,TOPSAKAL R,Oğuzhan A Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. . 2021; 282 - 287. 10.14744/etd.2020.22308
Vancouver ELÇİK D,Kelesoglu S,Dogan A,BİNGÖL B,ÇETİNKAYA Z,İİNANÇ M,KALAY N,TOPSAKAL R,Oğuzhan A Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. . 2021; 282 - 287. 10.14744/etd.2020.22308
IEEE ELÇİK D,Kelesoglu S,Dogan A,BİNGÖL B,ÇETİNKAYA Z,İİNANÇ M,KALAY N,TOPSAKAL R,Oğuzhan A "Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome." , ss.282 - 287, 2021. 10.14744/etd.2020.22308
ISNAD ELÇİK, Deniz vd. "Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome". (2021), 282-287. https://doi.org/10.14744/etd.2020.22308
APA ELÇİK D, Kelesoglu S, Dogan A, BİNGÖL B, ÇETİNKAYA Z, İİNANÇ M, KALAY N, TOPSAKAL R, Oğuzhan A (2021). Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. Erciyes Medical Journal, 43(3), 282 - 287. 10.14744/etd.2020.22308
Chicago ELÇİK Deniz,Kelesoglu Saban,Dogan Ali,BİNGÖL Bilge,ÇETİNKAYA Zeki,İİNANÇ M. Tuğrul,KALAY Nihat,TOPSAKAL Ramazan,Oğuzhan Abdurrahman Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. Erciyes Medical Journal 43, no.3 (2021): 282 - 287. 10.14744/etd.2020.22308
MLA ELÇİK Deniz,Kelesoglu Saban,Dogan Ali,BİNGÖL Bilge,ÇETİNKAYA Zeki,İİNANÇ M. Tuğrul,KALAY Nihat,TOPSAKAL Ramazan,Oğuzhan Abdurrahman Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. Erciyes Medical Journal, vol.43, no.3, 2021, ss.282 - 287. 10.14744/etd.2020.22308
AMA ELÇİK D,Kelesoglu S,Dogan A,BİNGÖL B,ÇETİNKAYA Z,İİNANÇ M,KALAY N,TOPSAKAL R,Oğuzhan A Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. Erciyes Medical Journal. 2021; 43(3): 282 - 287. 10.14744/etd.2020.22308
Vancouver ELÇİK D,Kelesoglu S,Dogan A,BİNGÖL B,ÇETİNKAYA Z,İİNANÇ M,KALAY N,TOPSAKAL R,Oğuzhan A Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome. Erciyes Medical Journal. 2021; 43(3): 282 - 287. 10.14744/etd.2020.22308
IEEE ELÇİK D,Kelesoglu S,Dogan A,BİNGÖL B,ÇETİNKAYA Z,İİNANÇ M,KALAY N,TOPSAKAL R,Oğuzhan A "Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome." Erciyes Medical Journal, 43, ss.282 - 287, 2021. 10.14744/etd.2020.22308
ISNAD ELÇİK, Deniz vd. "Clinical Effect of Non-Dipper and Dipper Hypertensionin Patients with Acute Coronary Syndrome". Erciyes Medical Journal 43/3 (2021), 282-287. https://doi.org/10.14744/etd.2020.22308